TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 36 filers reported holding TALIS BIOMEDICAL CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18 | – | 40 | -75.5% | 0.00% | – |
| Q3 2022 | $0 | – | 163 | +1.2% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 161 | -99.6% | 0.00% | – |
| Q1 2022 | $52,000 | -73.1% | 36,958 | -23.0% | 0.00% | – |
| Q4 2021 | $193,000 | -52.8% | 48,023 | -26.6% | 0.00% | – |
| Q3 2021 | $409,000 | +77.8% | 65,394 | +214.5% | 0.00% | – |
| Q2 2021 | $230,000 | -51.1% | 20,795 | -43.1% | 0.00% | – |
| Q1 2021 | $470,000 | – | 36,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,235,783 | $1,095,534 | 0.06% |
| Baker Brothers Advisors | 7,624,835 | $3,736,169 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 223,934 | $109,728 | 0.01% |
| ArrowMark Colorado Holdings LLC | 478,862 | $234,642 | 0.00% |
| WELLS FARGO & COMPANY/MN | 167 | $82 | 0.00% |
| NORTHERN TRUST CORP | 27,860 | $13,652 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 144,416 | $70,763 | 0.00% |
| STATE STREET CORP | 49,536 | $24,273 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 163,663 | $80 | 0.00% |